CClinicalTrials.gg
Not yet recruitingNCT07466615Updated Mar 12, 2026

Sensory Integration Training for Older Adults With Mild Cognitive Impairment

An interventional study of Aerobic Exercise and Sensory Integration Training in Mild Cognitive Impairment (MCI), sponsored by Akdeniz University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 65 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-03-12.

Sponsored by Akdeniz University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
65 Years to 85 Years
Sex
All
01

Study summary

This study aims to investigate the effects of sensory integration training on cognitive functions, quality of life, and social participation in older adults with Mild Cognitive Impairment (MCI)

Read the detailed description

Sensory impairments are highly prevalent among older adults and have significant effects on the cognitive and functional outcomes of aging. Although the relationship between sensory functions and cognitive processes has been clearly established in the literature, the underlying neurobiological and psychosocial mechanisms of this link are yet to be fully elucidated. In an era of increasing dementia prevalence, older individuals with sensory deficiencies constitute a critical and growing risk group that warrants investigation for a deeper understanding of cognitive aging. Epidemiological data indicate that impairments in visual, auditory, and other individual sensory systems are consistently associated with cognitive decline and the development of dementia.

In this context, our study proposes sensory integration training as a potential intervention to bridge the gap between sensory input and cognitive performance.

02

Conditions studied

  • Mild Cognitive Impairment (MCI)

Keywords

  • Mild Cognitive Impairment
  • Sensory Processing
  • Sensory Integration Training
  • Cognitive Function
03

In context

Cognitive Dysfunction

3,843 studies on the registry are indexed under Cognitive Dysfunction; 1,100 are open to participants now.

This study's planned enrollment of 40 is below the median of 65 across 2,808 interventional studies indexed under Cognitive Dysfunction.

Browse Cognitive Dysfunction studies →

Lead sponsor

Akdeniz University is the lead sponsor of 289 studies on the registry; 60 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Being between 65 and 85 years of age
  • Having a Montreal Cognitive Assessment (MoCA) score between 18 and 25, indicating mild cognitive impairment
  • Being in stable medical health, with no history of severe neurological or psychiatric disorders
  • Voluntary participation

Exclusion criteria

Exclusion Criteria:

  • Clinical diagnosis of dementia or having moderate-to-severe cognitive impairment
  • Severe visual or hearing loss to a degree that prevents effective communication or participation in assessments
  • Presence of severe sensory, motor, or physical disabilities that render the intervention (e.g., walking or sensory training) impossible to perform
  • Acute medical conditions or having unstable chronic diseases that may pose a risk during physical activity.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Aerobic Exercise +Sensory Integration Training

    Other: Aerobic Exercise · Other: Sensory Integration Training

  • Active comparator
    Aerobic Exercise

    Other: Aerobic Exercise

Interventions

  • OtherAerobic Exercise

    The aerobic exercise intervention consists of a 12-week outdoor walking program, performed twice weekly for 45 minutes per session at a moderate intensity, targeting a score of 12-14 on the Borg Rating of Perceived Exertion (RPE) scale

  • OtherSensory Integration Training

    The program includes activities that stimulate three main senses: vestibular (balance and movement), proprioceptive (body awareness), and tactile (touch). These exercises are designed to help the brain organize sensory signals more effectively to improve daily functions and cognitive performance.

06

What researchers measure

Primary outcomes

  1. Quick Mild Cognitive Impairment Screen - Turkish Version

    Quick Mild Cognitive Impairment Screen - Turkish Version is a cognitive assessment tool consisting of six sub-headings covering at least five cognitive domains. The sub-headings and the cognitive domains they assess are defined as follows: 1. Orientation: (Questioning the country, year, month, day, and date - approx. 1 minute - 10 points) 2. Registration: (Working memory; repeating 5 given words - 30 seconds - 5 points) 3. Clock Drawing: (Visuospatial; drawing a clock within 1 minute - 15 points) 4. Delayed Recall: (Episodic memory; recalling the 5 previously mentioned words - 30 seconds - 20 points) 5. Verbal Fluency: (Semantic memory/language; naming animals within 1 minute - 20 points) 6. Logical Memory: (Episodic memory; repeating a short story - 1 minute - 30 points) Scoring and Interpretation The test is evaluated out of a total of 100 points, where higher scores indicate better cognitive status. A score of 62 points or below indicates cognitive impairment.

    Time frame: 6 months

Secondary outcomes

  1. World Health Organization Quality of Life - Older Adults Module

    World Health Organization Quality of Life-Old module is a specialized 24-item instrument designed to evaluate the quality of life in older adults across six distinct domains, utilized via a five-point Likert scale. These domains include sensory abilities, which assesses the impact of sensory functions and their loss on quality of life; autonomy, reflecting independence and the ability to live and make decisions autonomously; past, present, and future activities, which measures satisfaction with life achievements and outlook on the future; social participation, focusing on engagement in daily community activities; death and dying, addressing concerns and anxieties related to the end of life; and intimacy, evaluating the capacity for personal and private relationships. Each item is scored on a scale from 1.0 to 5.0, resulting in potential domain scores ranging from a minimum of 4 to a maximum of 20. A total cumulative score is calculated by summing the individual item v

    Time frame: 6 months

  2. Lubbes Social Network Scale-6

    Lubbes Social Network Scale-6 is a specialized instrument comprising six items designed to evaluate the size of a social network, private communication (confiding), and the availability of reciprocal help. The scale is structured into two subscales, with three questions dedicated to family ties and three to friendship networks. Consistent with the original version, each item is rated on a six-point Likert scale ranging from 0 to 5. In this scoring system, individual scores of 0, 1, and 2 indicate a limited or deficient social network, whereas scores of 3, 4, and 5 signify a more extensive and robust social network. The total score is calculated by summing the values of all items, resulting in a range from 0 to 30. Higher total scores on the LSNS-6 are indicative of a greater presence of social network ties and more significant social engagement.

    Time frame: 6 months

07

Study locations

1 site
  • Isparta Şehir Hastanesi
    Isparta, Merkez, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07466615
Lead sponsor
Akdeniz University
Responsible party
Fatmagul Cayir (STUDENT, Akdeniz University) — Principal investigator
First posted
Mar 12, 2026
Start date
Mar 15, 2026 (estimated)
Primary completion
Dec 2026 (estimated)
Completion
Mar 2027 (estimated)
Last update
Mar 12, 2026

Study contacts

Fatmagül Çayır
Contact
fatmagul.cayir@hotmail.com
+ 90 530 0369530

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion